Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes

Background. Cardiac masses (CM) represent a heterogeneous clinical scenario, and sex-related differences of these patients remain to be established. Purpose: To evaluate sex-related disparities in CMs regarding clinical presentation and outcomes. Material and Methods. The study cohort included 321 consecutive patients with CM enrolled in our Centre between 2004 and 2022. A definitive diagnosis was achieved by histological examination or, in the case of cardiac thrombi, with radiological evidence of thrombus resolution after anticoagulant treatment. All-cause mortality at follow-up was evaluated. Multivariable regression analysis assessed the potential prognostic disparities between men and women. Results. Out of 321 patients with CM, 172 (54%) were female. Women were more frequently younger (p = 0.02) than men. Regarding CM histotypes, females were affected by benign masses more frequently (with cardiac myxoma above all), while metastatic tumours were more common in men (p < 0.001). At presentation, peripheral embolism occurred predominantly in women (p = 0.03). Echocardiographic features such as greater dimension, irregular margin, infiltration, sessile mass and immobility were far more common in men. Despite a better overall survival in women, no sex-related differences were observed in the prognosis of benign or malignant masses. In fact, in multivariate analyses, sex was not independently associated with all-cause death. Conversely, age, smoking habit, malignant tumours and peripheral embolism were independent predictors of mortality. Conclusions. In a large cohort of cardiac masses, a significant sex-related difference in histotype prevalence was found: Benign CMs affected female patients more frequently, while malignant tumours affected predominantly men. Despite better overall survival in women, sex did not influence prognosis in benign and malignant masses.

[1]  P. Rucci,et al.  Echocardiographic Markers in the Diagnosis of Cardiac Masses. , 2023, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  G. Boriani,et al.  2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal.

[3]  G. Boriani,et al.  2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). , 2022, European heart journal. Cardiovascular Imaging.

[4]  P. Rucci,et al.  Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature , 2022, Frontiers in Cardiovascular Medicine.

[5]  P. Rucci,et al.  Development and Validation of a Diagnostic Echocardiographic Mass Score in the Approach to Cardiac Masses. , 2022, JACC. Cardiovascular imaging.

[6]  C. Pizzi,et al.  [Cardiac masses: classification, clinical features and diagnostic approach]. , 2022, Giornale italiano di cardiologia.

[7]  S. Fredericks,et al.  Sex differences in mortality after first time, isolated coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized controlled trials. , 2022, European journal of cardiovascular nursing.

[8]  A. Islam Cardiac myxomas: A narrative review , 2022, World journal of cardiology.

[9]  C. Pizzi,et al.  Malignant Anterior ST-Segment Elevation. , 2022, JAMA internal medicine.

[10]  R. Lorusso,et al.  Sex differences in primary malignant cardiac tumors: A multi‐institutional cohort study from National Cancer Database , 2022, Journal of cardiac surgery.

[11]  M. Shawarby,et al.  Cardiac Myxoma: Typical Presentation but Unusual Histology , 2021, Case reports in medicine.

[12]  P. Rucci,et al.  Clues and pitfalls in the diagnostic approach to cardiac masses: are pseudo-tumours truly benign? , 2021, European journal of preventive cardiology.

[13]  John Quackenbush,et al.  Genome-Wide Sex and Gender Differences in Cancer , 2020, Frontiers in Oncology.

[14]  E. Fabris,et al.  Cardiac Tumors: Diagnosis, Prognosis, and Treatment , 2020, Current Cardiology Reports.

[15]  S. Fanti,et al.  Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses. , 2020, JACC. Cardiovascular imaging.

[16]  M. Taha,et al.  Survival Differences in Men and Women With Primary Malignant Cardiac Tumor: An Analysis Using the Surveillance, Epidemiology and End Results (SEER) Database From 1973 to 2015 , 2020, Journal of the American Heart Association.

[17]  P. Rahko,et al.  Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. , 2019, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  A. Moon,et al.  Sex Differences in Cancer: Epidemiology, Genetics and Therapy , 2018, Biomolecules & therapeutics.

[19]  S. Rizzo,et al.  Cardiac masses and tumours , 2016, Heart.

[20]  A. Burke,et al.  The 2015 WHO Classification of Tumors of the Heart and Pericardium. , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[21]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[22]  V. Rao,et al.  Molecular Basis of Cardiac Myxomas , 2014, International journal of molecular sciences.

[23]  Uichi Ikeda,et al.  Clinical classification of cardiovascular tumors and tumor-like lesions, and its incidences , 2013, General Thoracic and Cardiovascular Surgery.

[24]  M. Tevfik Dorak,et al.  Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue , 2012, Front. Gene..

[25]  C. Bruce Cardiac tumours: diagnosis and management , 2010, Heart.

[26]  M. Link,et al.  Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[27]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  R. Bugiardini,et al.  Left ventricular metastasis from uterine leiomyosarcoma. , 1999, Cardiologia.

[29]  T A Beery,et al.  Gender bias in the diagnosis and treatment of coronary artery disease. , 1995, Heart & lung : the journal of critical care.

[30]  OUP accepted manuscript , 2022, European Journal of Cardiovascular Nursing.

[31]  J. Voigt,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  H. Tazelaar,et al.  Cardiovascular pseudoneoplasms. , 2010, Archives of pathology & laboratory medicine.

[33]  V. Fowler,et al.  Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis , 2000 .